Biography:
Lloyd is a scientist with 25-year experience in drug development and clinical trials management. Lloyd serves as the chairman of Biomed Industries, Inc., the parent company of Biomed Pharmaceuticals, Biomed AI and NeuroActiva, Inc. Lloyd is the inventor of a number of patents and pending patents in the areas of neurodegenerative diseases and drug delivery systems. In his early career, he was employed as a research scientist at G.D. Searle, (a subsidiary of Pfizer), and was the director of R&D at Biomed Pharmaceuticals. Lloyd graduated with a BSc.(Honours) and completed a PhD in medicinal chemistry at University of Otago and Wellington University of New Zealand
Title : INTRODUCING the neurogenesis hypothesis with a case study- phase 2A clinical trials of na-831 for the treatment of Alzheimer's disease